Showing 1 – 6 of 6 results.
Curated
Comparison of Drug Control Strategies in San Diego, 1989 (ICPSR 9990)
Released/updated on: 2000-03-21
Geographic coverage: San Diego, United States, California
This study assesses the consequences for offenders of various drug enforcement strategies employed by the San Diego Police Department and profiles the factors that characterize street-level and mid-level dealers, drug users, and the drug market. The drug enforcement strategies examined include the use of search warrants, body wires, police decoys, surveillance, officer buys and sells, wiretaps, and sweeps. Measures of the consequences of arrests include drug and property seizures, convictions, and sentences. The data were drawn from police and court records of drug arrests made by three special sections of the police department in San Diego, California. Additionally, data were collected through personal interviews conducted at the time of arrest with a subsample of persons arrested for drug charges. The arrest tracking file, Part 1, contains demographic information about the offenders, including criminal history and gang membership, as well as data on each arrest through final disposition, charges, and sentencing. The interview portion of the study, Part 2, provides information about the demographics and characteristics of drug users and dealers, criminal history and drug use history, current arrest information, and offenders' opinions about drug use, drug sales, police strategies, and the drug market.
Curated
Differences in the Validity of Self-Reported Drug Use Across Five Factors in Indianapolis, Fort Lauderdale, Phoenix, and Dallas, 1994 (ICPSR 2706)
Released/updated on: 2000-09-11
Geographic coverage: Indiana, United States, Texas, Fort Lauderdale, Phoenix, Florida, Dallas, Arizona, Indianapolis
This study investigated the accuracy of self-reported drug use in three ways. First, the researchers examined differences in the accuracy of self-reported drug use across five factors: gender, race, age, type of drug, and offense seriousness. Second, an attempt was made to determine the specific sources of inaccurate self-reports in terms of differences in underreporting and overreporting. Third, the researchers sought to explain differences in underreporting and overreporting in terms of true differences or differences in opportunity to underreport or overreport. This study used data collected in 1994 as part of the Drug Use Forecasting (DUF) Program [DRUG USE FORECASTING IN 24 CITIES IN THE UNITED STATES, 1987-1997 (ICPSR 9477)]. The DUF drug testing and measurement methodology allows the accuracy of self-reported drug use to be checked with a biological criterion, namely urine tests. The sample for this study consisted of 4,752 white and Black adults from Indianapolis, Ft. Lauderdale, Phoenix, and Dallas. The five exogenous measures included in this study were type of drug (marijuana vs. crack/cocaine), age (18 through 30 vs. 31 or over), offense seriousness (misdemeanor vs. felony), race (Black vs. white), and gender (male vs. female). The endogenous measures were accuracy (self-report and drug test both positive or both negative vs. otherwise), underreporting (self-report negative but drug test positive vs. otherwise), and overreporting (self-report positive but drug test negative vs. otherwise). Variables include result of marijuana urine test, result of cocaine/crack urine test, marijuana self-report, cocaine/crack self-report, age group, sex, race, offense category, and ethnic/gender group.
Curated
Empirical Investigation of "Going to Scale" in Drug Interventions in the United States, 1990, 2003 (ICPSR 26101)
Released/updated on: 2009-08-26
Geographic coverage: United States
Despite a growing consensus among scholars that substance abuse treatment is effective in reducing offending, strict eligibility rules have limited the impact of current models of therapeutic jurisprudence on public safety. This research effort was aimed at providing policy makers some guidance on whether expanding this model to more drug-involved offenders is cost-beneficial. Since data needed for providing evidence-based analysis of this issue were not readily available, micro-level data from three nationally representative sources were used to construct a 40,320 case synthetic dataset -- defined using population profiles rather than sampled observation -- that was used to estimate the benefits of going to scale in treating drug involved offenders. The principal investigators combined information from the NATIONAL SURVEY ON DRUG USE AND HEALTH, 2003 (ICPSR 4138) and the ARRESTEE DRUG ABUSE MONITORING (ADAM) PROGRAM IN THE UNITED STATES, 2003 (ICPSR 4020) to estimate the likelihood of drug addiction or dependence problems and develop nationally representative prevalence estimates. They used information in the DRUG ABUSE TREATMENT OUTCOME STUDY (DATOS), 1991-1994 (ICPSR 2258) to compute expected crime reducing benefits of treating various types of drug involved offenders under four different treatment modalities. The project computed expected crime reducing benefits that were conditional on treatment modality as well as arrestee attributes and risk of drug dependence or abuse. Moreover, the principal investigators obtained estimates of crime reducing benefits for all crimes as well as select sub-types. Variables include age, race, gender, offense, history of violence, history of treatment, co-occurring alcohol problem, criminal justice system status, geographic location, arrest history, and a total of 134 prevalence and treatment effect estimates and variances.
Curated
Restricted
Evaluating a Presumptive Drug Testing Technology in Community Corrections Settings, 2011, Alabama, Florida and Wyoming (ICPSR 34494)
Released/updated on: 2016-04-12
Geographic coverage: United States, Wyoming, Alabama, Florida
Time period: 2011-02-01--2011-12-01
These data are part of NACJD's Fast Track Release and are distributed as they were received from the data depositor. The files have been zipped by NACJD for release, but not checked or processed except for the removal of direct identifiers. Users should refer to the accompanying readme file for a brief description of the files available with this collection and consult the investigator(s) if further information is needed.
This study was a multi-site evaluation of a presumptive drug detection technology (PDDT) developed by Mistral Security Incorporated (MSI). The evaluation was conducted by Justice and Security Strategies, Inc. (JSS) in work release programs, probation and parole offices, and drug courts in three states: Alabama, Florida, and Wyoming. Also, interviews with the offenders, corrections staff, and program administrators were conducted.
Curated
Evaluating Recidivism Among Drug Offenders in Florida's Residential and Non-Residential Substance Abuse Treatment Programs, 1991-1997 (ICPSR 2806)
Released/updated on: 2006-03-30
Geographic coverage: United States, Florida
Time period: 1991-01-01--1997-01-01
This study was undertaken to investigate the relationship, if any, between drug treatment and success or failure of drug-involved offenders on probation/community supervision. Further, the researchers sought to evaluate the outcomes of drug-involved offenders admitted to (1) secure residential substance abuse treatment (RSAT) programs, (2) non-secure residential drug treatment programs, (3) non-residential drug treatment programs, and (4) no drug treatment programs. Data were collected from administrative records provided by the Florida Department of Corrections, specifically case history records of offenders admitted to supervision in the community from July 1, 1991, through June 30, 1997. Part 1 is comprised of all cases admitted to community supervision between July 1, 1991, and June 30, 1993 (fiscal years 1991 and 1992) and treated in a secure residential drug treatment program. Part 2 is comprised of all cases admitted to community supervision from July 1, 1991, through June 30, 1995, receiving treatment in a non-secure residential drug treatment program. Part 3 contains data on offenders admitted to non-residential drug treatment programs, whose community supervision admissions were between July 1, 1991, and June 30, 1993. Part 4 contains data on offenders admitted to non-residential drug treatment programs, whose community supervision admissions were between July 1, 1993, and June 30, 1995 (fiscal years 1993 and 1994). Part 5 contains data on cases admitted to community supervision between July 1, 1991, and June 30, 1993, who did not receive drug treatment of any kind. Cases admitted to community supervision between July 1, 1993, and June 20, 1995, receiving no drug treatment are contained in Part 6. Each supervision admission record contains a history of subsequent court actions that were complete through December 31, 1997. Variables for all parts include population estimates, unemployment rates, population by age-specific categories, violent and nonviolent index offenses, per capita personal income, clearance rates, split sentence flag, primary offense disposition, primary offense felony level, current commitment years supervised, supervision type, whether current offense included a drug charge, number of prior supervision terms, number of prior commitments, reasons for failure, treatment facility code, number of drug sale/traffic offenses, outcome of supervision period, and reasons for prison intake. Demographic variables include race and gender.
Curated
Integrating the Ion Mobility Spectrometer Into Drug Monitoring at the New Orleans Pretrial Diversion Program, 1996 (ICPSR 3213)
Released/updated on: 2005-11-04
Geographic coverage: United States, Louisiana, New Orleans
This project was designed to evaluate the use of a drug detection instrument, the ion mobility spectrometer (IMS), and to integrate its use into an ongoing pretrial diversion program for nonviolent, first-time, drug-abusing offenders. The Pretrial Diversion Program in Orleans Parish, Louisiana, targeted offenders with limited arrest histories of nonviolent felony or misdemeanor violations. The majority of eligible participants were violators of simple drug possession statutes, primarily crack/cocaine or marijuana. Persons charged with drug distribution offenses were not eligible. In order to qualify for diversion, persons had to admit guilt regarding the acts for which they were arrested. The program was entirely voluntary. One of the unique aspects of this program was its aggressive use of drug testing, including urinalysis and hair analysis. This project evaluated the ability of the IMS to provide complete drug profile information to supervising agencies and assessed its usefulness to field staff engaged in drug monitoring duties. The project was based on the premise that enhanced information on offenders diverted into this program could create or improve several key aspects of program operation, such as client assessment, monitoring of compliance and progress, dispositional decision-making, client motivation, and staff morale. The study was designed to integrate the IMS into the normal operation of the New Orleans Pretrial Diversion Program with as little modification of existing treatment and supervision protocols as possible. Each client in the diversion program underwent an intensive intake assessment including an intake radioimmunoassay (RIA) hair assay and an additional RIA hair assay every 60 days. Each client was urine-tested at intake and assigned to a random test pool. The modified protocol for the project added an IMS-based scan or a hair specimen, skin wipe, and ten-second vacuum scan of clothing, hands, and axillae at intake. At each subsequent visit each client had a repeat IMS scan utilizing a skin swab and a scan of clothing or body area. Variables include self-reported cocaine use, self-reported marijuana use, IMS date, urinalysis date, hair assay results, urinalysis results, IMS detection, nicotine use, maximum amplitude, delta, cumulative amplitude, number of detections, whether the IMS showed a positive result, and the age, sex, and race of the client.